PMC:7463108 / 102349-102629 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T30 42-45 http://purl.obolibrary.org/obo/CLO_0051582 denotes has

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T54595 17-26 Chemical denotes methadone http://purl.obolibrary.org/obo/CHEBI_6807
T51815 28-41 Chemical denotes buprenorphine http://purl.obolibrary.org/obo/CHEBI_3216

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3508 195-198 Gene denotes MOR Gene:4988
3509 255-258 Gene denotes MOR Gene:4988
3521 17-26 Chemical denotes methadone MESH:D008691
3522 28-41 Chemical denotes buprenorphine MESH:D002047
3534 105-109 Disease denotes ARVs
3535 126-152 Disease denotes opioid withdrawal symptoms MESH:D013375

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1286 0-280 Sentence denotes In comparison to methadone, buprenorphine has been shown to have fewer pharmacodynamic interactions with ARVs and causes less opioid withdrawal symptoms potentially due to its partial agonism on MOR, but also due to its high affinity and long duration of MOR binding (Walsh et al.